Pub. Date:
Edward Elgar Publishing
Intellectual Property, Pharmaceuticals, and Public Health : Access to Drugs in Developing Countries

Intellectual Property, Pharmaceuticals, and Public Health : Access to Drugs in Developing Countries


Current price is , Original price is $160.0. You

Temporarily Out of Stock Online

Please check back later for updated availability.


This up-to-date book examines pharmaceutical development, access to medicines, and the protection of public health in the context of two fundamental changes that the global political economy has undergone since the 1970s, the globalization of trade and production and the increased harmonization of national regulations on intellectual property rights.

With authors from eleven different countries presenting case studies of national experiences in Africa, Asia and the Americas, the book analyzes national strategies to promote pharmaceutical innovation, while at the same time assuring widespread access to medicines through generic pharmaceutical production and generic pharmaceutical importation. The expert chapters focus on patents as well as an array of regulatory instruments, including pricing and drug registration policies.

Presenting in-depth analysis and original empirical research, this book will strongly appeal to academics and students of intellectual property, international health, international political economy, international development and law.

Product Details

ISBN-13: 9781849800143
Publisher: Edward Elgar Publishing
Publication date: 01/30/2012
Pages: 352
Product dimensions: 6.00(w) x 9.30(h) x 1.00(d)

About the Author

Edited by Kenneth C. Shadlen, London School of Economics and Political Science, UK, Samira Guennif, Université Paris 13, France, Alenka Guzmán, Autonomous Metropolitan University-Iztapalapa, Mexico and Narayanan Lalitha, Gujarat Institute of Development Research, India

Table of Contents


1. Globalization, Intellectual Property Rights, and Pharmaceuticals: Meeting the Challenges to Addressing Health Gaps in the New International Environment

Kenneth C. Shadlen, Samira Guennif, Alenka Guzmán and N. Lalitha

2. Pharmaceutical Production and Access to Essential Medicines in South Africa

Heinz Klug

3. Intellectual Property and Access to Medicines: Paradoxes in Moroccan Policy

Gaëlle Krikorian

4. The Invisible Threat: Trade, Intellectual Property, and Pharmaceutical Regulations in Colombia

Tatiana Andia

5. The Challenges of Constructing Pharmaceutical Capabilities and Promoting Access to Medicines in Mexico under TRIPS

Alenka Guzmán

6. Corporate Power and State Resistance: Brazil’s Use of TRIPS Flexibilities for its National AIDS Program

Matthew Flynn

7. The Politics of Patents and Drugs in Brazil and Mexico: The Industrial Bases of Health Policies

Kenneth C. Shadlen

8. Pharmaceutical Patent Policy in Developing Countries: Learning from the Canadian Experience

Jean-Frédéric Morin and Mélanie Bourassa Forcier

9. Access to Indian Generic Drugs: Emerging Issues

N. Lalitha

10. Sufficient but Expensive Drugs: A Double-Track System that Facilitated Supply Capability in China

Mariko Watanabe and Luwen Shi

11. Access to Essential Drugs in Thailand: Intellectual Property Rights and Other Institutional Matters Affecting Public Health in a Developing Country

Samira Guennif

12. The TRIPS Agreement and Health Innovation in Bangladesh

Padmashree Gehl Sampath


Customer Reviews